Shareholders of Revance Therapeutics, Inc. Should Contact Levi & Korsinsky Before March 4, 2025 to Discuss Your Rights - RVNC

NEW YORKJan. 21, 2025Revance Therapeutics, Inc.CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Revance investors who were adversely affected by alleged securities fraud between February 29, 2024 and December 6, 2024. Follow the link below to get more information and be contacted by a member of our team:https://zlk.com/pslra-1/revance-therapeutics-inc-lawsuit-submission-form?prid=123844&wire=4 RVNC investors may also contact Joseph E. Levi, Esq. via email at [email protected] or by telepho ...